Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Meier

Showing results (131-140 of 158) with videos related to

Pageof 16
Sort By:
Pulmonary Circulation|May 11, 2013
Updating clinical endpoint definitionsPaul M Hassoun, Sylvia Nikkho, Erika B Rosenzweig, et al.
Archives of Internal Medicine|January 16, 2008
Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology StudyChristian Meier, Tuan V Nguyen, David J Handelsman, et al.
Swiss Medical Weekly|September 6, 2017
Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCOChristian Meier, Brigitte Uebelhart, Bérengère Aubry-Rozier, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 11, 2017
REVEAL risk scores applied to riociguat-treated patients in PATENT-2: Impact of changes in risk score on survivalRaymond L Benza, Harrison W Farber, Adaani Frost, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and MaliPanchali Roy Chowdhury, Christian Meier, Hewad Laraway, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 14, 2005
Ubiquitin-associated domain mutations of SQSTM1 in Paget's disease of bone: evidence for a founder effect in patients of British descentGavin J A Lucas, Lynne J Hocking, Anna Daroszewska, et al.
Journal of Cardiovascular Pharmacology|February 16, 2022
Muscarinic Receptor Activation Reduces Force and Arrhythmias in Human Atria Independent of IK,AChJohannes Petersen, Liesa Castro, Anne K P Bengaard, et al.
Annals of the Rheumatic Diseases|July 27, 2016
Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2Marc Humbert, J Gerry Coghlan, Hossein-Ardeschir Ghofrani, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 1, 2021
Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT studyRaymond L Benza, Athénaïs Boucly, Harrison W Farber, et al.
Pulmonary Circulation|December 7, 2020
Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertensionOlivier Sitbon, Sylvia Nikkho, Raymond Benza, et al.
Pageof 16

Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
Pulmonary Circulation|May 11, 2013
Updating clinical endpoint definitionsPaul M Hassoun, Sylvia Nikkho, Erika B Rosenzweig, et al.
Archives of Internal Medicine|January 16, 2008
Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology StudyChristian Meier, Tuan V Nguyen, David J Handelsman, et al.
Swiss Medical Weekly|September 6, 2017
Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCOChristian Meier, Brigitte Uebelhart, Bérengère Aubry-Rozier, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 11, 2017
REVEAL risk scores applied to riociguat-treated patients in PATENT-2: Impact of changes in risk score on survivalRaymond L Benza, Harrison W Farber, Adaani Frost, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and MaliPanchali Roy Chowdhury, Christian Meier, Hewad Laraway, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 14, 2005
Ubiquitin-associated domain mutations of SQSTM1 in Paget's disease of bone: evidence for a founder effect in patients of British descentGavin J A Lucas, Lynne J Hocking, Anna Daroszewska, et al.
Journal of Cardiovascular Pharmacology|February 16, 2022
Muscarinic Receptor Activation Reduces Force and Arrhythmias in Human Atria Independent of IK,AChJohannes Petersen, Liesa Castro, Anne K P Bengaard, et al.
Annals of the Rheumatic Diseases|July 27, 2016
Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2Marc Humbert, J Gerry Coghlan, Hossein-Ardeschir Ghofrani, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 1, 2021
Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT studyRaymond L Benza, Athénaïs Boucly, Harrison W Farber, et al.
Pulmonary Circulation|December 7, 2020
Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertensionOlivier Sitbon, Sylvia Nikkho, Raymond Benza, et al.
Pageof 16